Although cosmetic surgery is an optional procedure, it is still a complex operation which could involve serious complications. However, some people do not consider the risks of cosmetic surgery malpractice before going "under the knife" and fail to make simple steps to check the qualifications and… Read More
Avandia has been the subject of a lot of attention recently as a result of studies which found that the type II diabetes drug increases the risk of heart problems. A new study released this week provides additional information about another Avandia side effect, which could… Read More
Diabetes associations from the United States and Europe indicated this week that doctors should exercise greater caution when prescribing oral type 2 diabetes drugs like Avandia and Actos. An increased risk of heart attacks has been associated with Avandia, and both diabetes drugs have been linked… Read More
Approximately 235,000 individuals have one of the recently recalled Medtronic defibrillator wires implanted in their chest. According to initial estimates, about 4,000 to 5,000 people could have their lead fracture or break. However, experts are not recommending that doctors replace Medtronic defibrillator leads which have been… Read More
According to a recent report from the New York Post, at least 235 deaths could be blamed on Trasylol side effects. The heart surgery drug given to control bleeding has been linked to problems such as an increased risk of kidney damage, congestive heart failure, heart… Read More
Medtronic, Inc. announced a significant drop in sales for their defibrillator business during the third quarter following the recent Sprint Fidelis recall. The company estimates that they have already lost about $130 million in sales as a result of the Medtronic wire recall, and they also… Read More
The FDA and GlaxoSmithKline officially announced earlier this week that an Avandia black box warning will be added to the diabetes drug regarding heart attacks. However, many do not believe that the warning does enough to inform users about the risk of serious injury or death… Read More
The makers of Avandia, GlaxoSmithKline, PLC, have placed new restrictions in Canada on the use of their popular type II diabetes drug. The new labeling comes after a Health Canada review of clinical data found an increased risk of heart related problems. Earlier this year, a… Read More
Merck & Co. announced this morning that a Vioxx settlement was reached which could cover about 50,000 of the claims presented against the company. According to the terms of the agreement, Merck will pay $4.85 billion into a fund for qualifying claims, which is expected to… Read More
The FDA announced today that they requested Bayer Pharmaceuticals halt further sales of Trasylol pending their review of data from a Canadian study which suggests that the heart surgery injection significantly increases the risk of death. The injection has been under scrutiny from regulators for nearly… Read More
